This is a multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority clinical study in women aged 35 to 42 years. This study will investigate the safety and efficacy of Progesterone-IBSA to support euploid embryo blastocyst implantation and early pregnancy after frozen embryo transfer (FET) in a modified natural cycle as a treatment for infertile women. Subjects will be randomized to receive either active Progesterone-IBSA or Crinone 8% for luteal and early pregnancy support and these two groups will be compared.
2 Primary · 11 Secondary · Reporting Duration: from 5 weeks post embryo transfer until the 12th week of pregnancy.
680 Total Participants · 2 Treatment Groups
Primary Treatment: Investigational · Has Placebo Group · Phase 3
Age 18 - 65 · Female Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: